Clinical utility and diagnostic accuracy of the GAAD score in non-cirrhotic patients with focal liver lesions

Key Points

• To assess the diagnostic accuracy of the GAAD score for detecting hepatocellular carcinoma (HCC) in non-cirrhotic patients with focal liver lesions.
• Cohort design involving non-cirrhotic patients with focal liver lesions
• Comparison of GAAD score with AFP and PIVKA-II
• Evaluation of diagnostic accuracy metrics
• GAAD score showed high predictive capability for HCC
• Provided superior accuracy compared to AFP and PIVKA-II
• Support for using GAAD score in clinical management decisions for these patients